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Progressive increase in ventriculo-arterial impedance is associated
with LV disfunction and adverse outcomes in patients with severe aor-
tic stenosis
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Introduction: ventriculo-arterial impedance (ZVa) is recognised as influencing
exercise tolerance, sincope onset and prognosis in aortic stenosis (AS) patients 
Aim: of the present study is to show that increase in ZVa is associated with
impairment of left ventricular (LV) function and adverse outcome in AS.
Methods: 218 patients (mean age: 79.9±8.6 years, males: 54%) with
severe AS (aortic surface<1cm2 or <0.6cm2/m2) underwent standard echocar-
diography to characterize aortic valve gradients, biventricular function and
ZVa. At follow-up, hospitalization for cardiac cause, heart failure and overall
death were considered as major adverse cardiac events (MACEs).
Results: according to ZVa values our population was divided in four
groups (Table 1). Progressive increase in ZVa was associated with a progres-
sive reduction in LV ejection fraction (LVEF), mitral S’, indexed stroke
volume (SVi) and LV global longitudinal strain (GLS). At Kaplan-Meyer sur-
vival analysis, a ZVa >3.43 mmHg/ml/m2, as observed in Group B, C and D
patients, was associated with a poor prognosis (Log-Rank test, p=0.02)
Conclusions: in patients with severe AS, progressive increase in ventri-
culo-arterial impedance has a negative impact on LV performance, and a mild
elevation in ventriculo-arterial impedance is associated with a poor prognosis.
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Determinants and prognostic impact of left ventricular contractile
reserve in asymptomatic aortic stenosis
Julien Magne (1), Erwan Donal (2), Raluca Dulgheru (1), Luc A. Piérard (1),
Patrizio Lancellotti (1)
(1) CHU Sart Tilman, Cardiologie, Liège, Belgique – (2) CHU Rennes,
Rennes, France
Background: The management of asymptomatic patients with severe
aortic stenosis (AS) is extremely controversial. There are very few data
regarding the assessment, determinants and prognostic value of left ventricular
contractile reserve (LVCR) in these patients. We aimed to quantify LVCR and
to evaluate its determinants and usefulness for risk stratification in asympto-
matic patients with severe AS.
Methods and results: Asymptomatic patients with severe AS (n=150,
aortic valve area<1cm², 70±9 years, 64% of male) and preserved left ventri-
cular (LV) systolic function (LV ejection fraction ≥55%) were prospectively
referred to exercise stress echocardiography. Using 2D speckle tracking ana-
lysis, LVCR was defined as an exercise-induced changes in LV global longi-
tudinal strain >2%. LVCR was present in 62 patients (41%) and there was no
significant difference between LVCR and no LVCR groups regarding demo-
graphic, clinical and exercise data, as well as risk factors. Using multiple
linear regression, after adjustment for age, sex and E/Ea ratio, the independent
determinant of exercise-induced changes in LV global longitudinal strain were
aortic mean pressure gradient (p=0.005), LV ejection fraction (p=0.035) and
exercise indexed LA area (p=0.002). During a mean follow-up of 19±12
months, 76 events (51%) occurred. The absence of LVCR was associated with
reduced 4-year cardiac event-free survival (26±6 vs. 53±11%, p<0.0001). By
opposition, exercise-induced changes in LV ejection fraction did not predict
the outcome (p=0.96). In multivariate analysis, the independent predictors of
events were resting brain natriuretic peptide level (p<0.0001), aortic mean
pressure gradient (p=0.037), exercise cardiac output (p=0.004) and absence of
LVCR (HR=1.8, 95%CI: 1.05-3.08, p=0.033).
Conclusion: In asymptomatic patients with severe AS, the main determinants
of LVCR, as assessed using exercise-induced changes in LV global longitudinal
strain, were related to AS severity and exercise LA size. The absence of LVCR is
a powerful predictor of reduced cardiac event-free survival. These results strongly
support the use of exercise stress echocardiography in asymptomatic AS. 
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Prognostic value of NT-proBNP in Algerian patients with asymptoma-
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Introduction and objectives: Aortic stenosis (AS) is the most common
valve disease. Aortic valve replacement (AVR) is the treatment of choice in
symptomatic patients with severe AS. Our objective was to assess the prog-
nostic value of NT-proBNP in Algerian patients with asymptomatic moderate/
severe aortic. 
Methods: Prospective study of 225 patients with degenerative asymptomatic
moderate/severe aortic stenosis. NT-proBNP was determined in all patients, who
were then followed up clinically. A clinical event was defined as surgery, hos-
pital admission due to angina, heart failure or syncope, or death. 
Results: A total of 51% were women, and the mean age was 74 years.
Mean (SD) echocardiographic values were as follows: peak velocity 4.14
(0.87) m/s; mean gradient, 43.2 (16.0) mmHg; aortic valve area, 0.87 (0.72) cm2,
and aortic valve area index, 0.49 (0.14) cm2/m2. The median NT-pro-BNP
value was 490.0 [198.0-1312.0] pg/mL. There were 139 events during follow-
up (median 12 months). The optimum NT-proBNP cut-point was 515 pg/mL,
giving event-free survival rates at 6 months and 1 years of 93% and 57%,
respectively, in patients with NT-proBNP <515 pg/mL compared with 50%
and 31% in those with NT-proBNP >515 pg/mL. 
Conclusions: NT-proBNP determination provides prognostic information
in patients with asymptomatic moderate/severe aortic stenosis.
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Balloon mitral valvotomy for patients with mitral stenosis in atrial
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Gamra
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Background: Atrial fibrillation (AF) is a common finding in patients with
severe mitral stenosis requiring Balloon Mitral Valvotomy (BMV). Its imme-
diate and long term prognosis remains controversial.
Abstract 0087 – Table1
Table 1
Group A
ZVa≤3.43 
mmHg/ml/m2
Group B
3.43<ZVa≤4.1 
mmHg/ml/m2
Group C
4.1<ZVa≤5.10
mmHg/ml/m2
Group D
ZVa>5.10
mmHg/ml/m2
ANOVA
p-value
LVEF (%) 57.9±10.8 58.6±9.5 56.8±12.9 50.64±14.5 0.02
SVi (ml/m2) 49.6±14.0 47.3±7.1 40.9±5.9 31.6±6.8 <0.0001
Onde S’ (cm/sec) 6.2±1.2 6.5±1.6 6.21±1.9 5.6±1.5 0.05
GLS (%)  – 14.4±13.3  – 13.3±3.4  – 12.5±3.5  – 10.6±3.2 <0.0001
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Objectives: We sought to evaluate the effect of AF on the immediate and
long-term (23 years) outcome of patients undergoing BMV.
Methods: The immediate procedural and the long-term clinical outcome
after BMV of 139 patients with AF were collected and compared with those
of 381 patients in normal sinus rhythm (NSR). 
Results: Patients with AF were older (43.3 vs. 29.7 years; p < 0.001), had
frequently a history of systemic embolism (9.4% vs. 1.6%, p< 0.001) and of
mitral commissurotomy (28.1% vs. 19.4%, p=0.035). Patients with AF had
more frequently a Wilkins score > 8 (51.4% vs. 30.9%, p <0.001), a larger left
atrium (41cm2 vs. 32cm2, p= 0.001) and a lower transmitral gradient (11.1
mmhg vs. 16.6 mmhg, p < 0.001).
BMV was equally successful in the two groups (90.6% vs. 94%,
p=0.187) but resulted in a smaller post BMV area (2cm2 vs. 2.15cm2,
p=0.012) with a lower mitral valve area gain (0.9cm2 vs. 1 C, p=0.015).
BMV was not associated with a higher risk of complications (4.3% vs.
4.7%, p= 0.844).
After a mean follow-up of 74 months, patients with AF had the same
rate of restenosis (28.3% vs. 25.6%, p=0.96) but required more frequently
a mitral valve replacement (16.3% vs. 7.7%, p= 0.012). They also experi-
enced higher rates of systemic embolism (3.8% vs. 0.6%, p=0.018) and
had a lower rate of event free survival (52.2% vs 68.8%, p= 0.047). In the
group of patients in AF, predictive factors for combined adverse events
including death, restenosis, and systemic embolism. Predictive factors of
mitral valve replacement are: post BMV area < 2cm2 (OR: 2.5, 95% CI
[1.2; 5.18], p= 0.014), procedural complications including severe mitral
regurgitation and tamponnade (OR: 3.95, p= 0.009) and NYHA ≥ II during
follow up (OR: 3.46, p <0.001).
Conclusion: Our data support the fact that patients with AF have worse
immediate and long term outcomes after BMV. Post BMV area <2cm2,
procedural complications and dyspnea predict adverse events during
follow up.
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Tricuspid valve-in-valve (VIV) implantation has recently emerged as a
possible therapeutic option when a bioprosthetic valve degenerates. A French
retrospective study is reported. 
From 2010 to end 2014, 9 patients underwent tricuspid VIV implantation.
There were 4 females and 5 males. Pts were in functional NYHA class III. Seven
pts had congenital heart disease, 1 pt a rheumatic disease, 1 pt a cardiomyopathy.
Causes for implantation were tricuspid stenosis (n = 4), a mixed lesion combining
tricuspid stenosis and regurgitation (n = 4), and one tricuspid regurgitation. In
addition, 2 of them suffered from protein losing enteropathy (PLE).
Implantation was performed under general anaesthesia using a femoral
approach at a mean age of 29.5±18 years (9-60 years). Two pts underwent
pre-dilatation of the lesion and a pre-stenting was performed in 6. VIV
implantation was realized under pacing in 3 pts. A 22-mm Melody valve
(Medtronic) was implanted in 6 pts, and an Edwards Sapien valve in 3 (one
23-mm, one 26mm, and one 29-mm valve). Implantation succeeded in all
despite 2 embolizations (1 in RA and 1 in RV); the embolized stent could be
stabilized within the tricuspid annulus in both by a self-expandable stent
before subsequent successful VIV implantation using a second valved stent.
During follow-up (mean 10 months and up to 24 months), all pts but one were
clinically ameliorated (mean functional NYHA class II) including the 2 pts
with PLE (increase in albumin level). The mean tricuspid gradient decreased
significantly from 9.4±2.3mm Hg before to 3.9±0.4mm Hg after implantation.
Two pts died during follow-up but death was not valved stent related. 
To conclude, tricuspid VIV implantation is an effective procedure using
both the Melody and the Edwards Sapien valves. Knowledge of the true min-
imal diameter is the key point to choose the appropriate valved stent. This
promising technique has good immediate and mid-term results but further
studies with longer follow-up and including more pts are necessary 
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Predictors of functional tricuspid regurgitation after successful left-
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Leila Bezdah, Mohamed Gzara, Ahmed Chetoui, Slim Sidhom, S.Moha-
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Introduction: Functional tricuspid regurgitation (TR) is probably the most
common and anticipated complication of left-sided heart valve pathology,
especially mitral valve diseases. Whether preoperative functional TR will
regress or progress after successful left-sided valve surgery is unknown. The
aim of this study was to identify the predictors of significant TR after suc-
cessful left-sided valve surgery.
Methods: A retrospective analysis was performed on a total of 56 patients
who underwent left-sided valve surgery (mitral or mitro-aortic valve surgery).
We have excluded patients who had organic TR.
All patients had complete clinical examination and echocardiographic
studies preoperatively and clinical and echocardiographic follow-up post-
operatively. 
Results: Mean operative age of patients was 49,3±13,7 years with a sex-
ratio of 0,8. Tricuspid annuloplasty was associated to left-sided valve surgery
in 18 (32%) patients. Postoperatively, significant TR was found in 13 patients
(23%) with a mean follow-up of 20,5±33 months. Patients with significant
postoperative TR were more often female (83% vs 48%, p = 0,03), had more
often a previous mitral commissurotomy (58% vs 23%, p=0,02) and showed a
higher prevalence of significant preoperative TR (69% vs 42%, p=0,04). Post-
operatively, residual pulmonary hypertension (p=0,04), dilatation of left
atrium (p=0,02) and dilatation of right cardiac cavities (p=0,01) were signifi-
cant risk factors for development or progression of TR after surgery. 
Conclusion: Late onset or progression of functional TR after successful
left-sided valve surgery is a significant clinical entity as it displays a great
impact on patient prognosis. So, the identification of clinical and echocardio-
graphic predictors of late TR allows an adequate screening of patients that will
require tricuspid valve repair at the time of initial left-sided valve surgery.
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Evaluation of the tricuspid annulus size: clinical implications from
comparison between 2D-transthoracic and 3D-transesophageal echo-
cardiography 
Julien Dreyfus, Guillaume Durand-Viel, C.Cimadevilla, Eric Brochet,
Alec Vahanian, David Messika-Zeitoun
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Background: Tricuspid annuloplasty is recommended during left-heart
valve surgery when tricuspid annulus (TA) is dilated, independently of the
degree of tricuspid regurgitation, but the methodology to measure TA and
thresholds are not clearly defined. We aimed to compare TA diameter (TAD)
measurements performed using bi-dimensional transthoracic echocardiography
(2D-TTE) in the 4 different views to three-dimensional measurements per-
formed during transesophageal echocardiography (3D-TEE) and to define
thresholds of TA enlargement for routine practice.
Methods: 2D-TTE measurement of the TAD was performed in para-
sternal long-axis view of the right ventricle inflow, parasternal short-axis,
apical 4-chamber (A4C) and sub-costal views in 195 prospectively enrolled
patients and 66 healthy volunteers. 3D dynamic volumetric datas of the TA
were also acquired by TEE using a matrix array transducer (X7-2t, Philips)
in the 195 patients. Multiplanar reconstructions were performed offline
using dedicated software (QLab7, Philips) to measure the long-axis (LA) of
the TA.
Results: In the 195 patients, TAD measurements were not different
between the 4 TTE views (P=0.13), but A4C was the most feasible and the
most reproducible method (Table). TAD measurement in A4C view by TTE
(3.90±0.62cm) was well correlated (r=0.84, p<0.0001) to LA by 3D-TEE
(4.33±0.63cm), but with a systematic 4mm underestimation. In the healthy
volunteers, mean value of TAD in A4C was 3.2±0.4cm or 1.8±0.23cm/m² and
the upper limit of 95% confidence interval was 4.2cm or 2.3cm/m².
